Results 221 to 230 of about 790,730 (234)

Prolonged TNF-α stimulation induces a PD-1-associated exhaustion-like phenotype in mesenchymal stromal cells. [PDF]

Front Cell Dev Biol
Matsunaga N, Akiyama K, Mun AY, Zou T, Ito K, Tagashira R, Kuboki T.   +6 more
europepmc   +1 more source

Cyclic Olefin Copolymers as Versatile Materials for Advanced Engineering Applications

Advanced Functional Materials, EarlyView.
Cyclic olefin copolymers (COCs) are presented as highly versatile materials combining tunable synthesis, excellent optical properties, and mechanical robustness. Their potential spans microfluidics, bioengineering, and advanced electronics, while emerging self‐healing and sustainable solutions highlight future opportunities.
Giulia Fredi, Norma Mallegni, Andrea Dorigato, Mario Milazzo   +3 more
wiley   +1 more source

APR-246 drives ROS-dependent ferroptosis and apoptosis and enhances anti-PD-1 efficacy in bladder cancer. [PDF]

Sci Rep
Zhang C, Cao S, Zeng G, Dong Y, Li H, Ma X, Zhang X, Li Z, Huang Y.   +8 more
europepmc   +1 more source

PD-1 Expression Promotes Immune Evasion in B-ALL. [PDF]

Hematol Rep
Casado-García A, García-Aguilera G, Pozo J, Oak N, Barrena S, Ruiz-Corzo B, Lalchandani J, Chamorro-Vera A, Castillo-Robleda A, Soriano B, Alemán-Arteaga S, Sánchez EG, Martínez-Cano J, López-Álvarez de Neyra A, Somoza-Cotillas P, Blanco O, Riesco S, Prieto-Matos P, García Criado FJ, García Cenador MB, Cobaleda C, Vicente-Dueñas C, Nichols KE, Orfao A, Ramírez-Orellana M, Sánchez-García I.   +25 more
europepmc   +1 more source

Peripheral blood biomarkers for predicting response to PD-1/PD-L1 inhibitors. [PDF]

Biomark Res
Chen S, Hu Y, Cheng H, Guo S, Han Y, Li K.   +5 more
europepmc   +1 more source

Dual blockades of TIM-3 and PD-1 effectively prevent hyper-progression and enhance the efficacy of anti-PD-1 therapy in high-grade serous ovarian cancer. [PDF]

Cell Death Dis
Li J, Zhou Y, Song Y, Dai G, Li X, Sun Y, Wang J, Wei R, Li F, Xi L.   +9 more
europepmc   +1 more source

Cordyceps sinensis enhances the efficacy of anti-PD-1 immunotherapy in Lewis lung adenocarcinoma. [PDF]

Sci Rep
Liu Y, Gao Y, Suonanlamao, Ma Y, Xiao Y, Wei L, Zhou W.   +6 more
europepmc   +1 more source

The efficacy of sequential radiotherapy after the combination of TACE with lenvatinib and anti-PD-1 antibodies for unresectable HCC. [PDF]

Oncologist
Ou X, Li J, Pan R, Liu D, Wu J, Liang D, Li Y, Zeng Z, Li H, Zhang Y, Wu J, Yan M.   +11 more
europepmc   +1 more source